Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

6.08
Delayed Data
As of Aug 31
 -0.20 / -3.18%
Today’s Change
3.33
Today|||52-Week Range
6.85
+45.80%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 7.75, with a high estimate of 8.00 and a low estimate of 7.00. The median estimate represents a +27.47% increase from the last price of 6.08.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.00
Sales
$25.7M
Reporting Date
Oct 21

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 

Sales

Growthquarterly 5.56%
 
 
 
 
 
 
Growthannually 15.95%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.